Narayana Hrudayalaya (NH)₹1,892−1.49%Hospital
In the Jun 2026 quarter (consolidated), Narayana Hrudayalaya reported sales of ₹2,678 Cr, up 78.1% from Jun 2025, and net profit of ₹208 Cr, up 5.0% year on year. For the year to Mar 2026, sales were ₹7,886 Cr and net profit ₹807 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,303 | 1,203 | 1,245 | 1,304 | 1,365 | 1,332 | 1,473 | 1,504 | 1,640 | 2,148 | 2,591 | 2,678 |
| Expenses | 999 | 928 | 957 | 1,007 | 1,061 | 1,029 | 1,120 | 1,174 | 1,247 | 1,791 | 2,091 | 2,221 |
| Operating Profit | 307 | 279 | 291 | 302 | 309 | 307 | 357 | 336 | 400 | 365 | 507 | 467 |
| OPM % | 24.1% | 23.1% | 23.0% | 23.1% | 23.1% | 23.1% | 24.1% | 22.1% | 24.1% | 17.1% | 20.1% | 17.1% |
| Other Income | 18.06 | 18.05 | 26.09 | 24.05 | 23.08 | 18.05 | 20.05 | 24.09 | 24.07 | −29.07 | 25.06 | 35.11 |
| Interest | 22.98 | 24.99 | 27.97 | 33.99 | 34.96 | 36.99 | 41.01 | 44.99 | 41.95 | 65.01 | 91.01 | 86.89 |
| Depreciation | 54.78 | 62.79 | 64.73 | 60.83 | 64.76 | 69.74 | 81.68 | 83.68 | 86.77 | 122 | 154 | 155 |
| Profit before tax | 248 | 209 | 225 | 231 | 232 | 219 | 255 | 232 | 296 | 149 | 288 | 260 |
| Tax % | 9.0% | 10.0% | 15.0% | 13.0% | 14.0% | 12.0% | 22.0% | 15.0% | 13.0% | 15.0% | 22.0% | 20.0% |
| Exceptional items | 0.00 | 0.00 | 2.99 | 0.99 | 0.00 | −0.99 | −4.99 | 0.99 | 0.00 | −41.85 | −3.99 | 0.00 |
| Net Profit | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 198 | 259 | 127 | 224 | 208 |
| EPS (Rs) | 11.08 | 9.19 | 9.32 | 9.84 | 9.71 | 9.43 | 9.64 | 9.61 | 12.63 | 6.19 | 10.95 | 10.13 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,611 | 1,875 | 2,277 | 2,856 | 3,121 | 2,580 | 3,694 | 4,514 | 4,884 | 5,474 | 7,886 | 9,056 |
| Expenses | 1,437 | 1,646 | 2,069 | 2,572 | 2,699 | 2,402 | 3,044 | 3,546 | 3,731 | 4,193 | 6,269 | 7,350 |
| Operating Profit | 180 | 236 | 217 | 295 | 433 | 189 | 663 | 985 | 1,166 | 1,296 | 1,639 | 1,739 |
| OPM % | 11.1% | 13.1% | 10.1% | 10.1% | 14.0% | 7.0% | 18.0% | 22.0% | 24.0% | 24.1% | 21.1% | 19.2% |
| Other Income | −19.07 | 7.02 | 18.05 | 16.06 | 7.02 | 21.05 | 26.06 | 59.17 | 73.24 | 80.21 | 37.09 | 55.17 |
| Interest | 32.97 | 27.99 | 54.94 | 80.90 | 93.90 | 81.97 | 75.93 | 83.99 | 112 | 163 | 266 | 285 |
| Depreciation | 75.74 | 79.74 | 99.70 | 137 | 185 | 183 | 182 | 209 | 240 | 277 | 447 | 517 |
| Profit before tax | 51.03 | 135 | 80.09 | 93.15 | 161 | −56.05 | 431 | 753 | 889 | 938 | 965 | 994 |
| Tax % | 59.0% | 39.0% | 36.0% | 37.0% | 26.0% | −75.0% | 20.0% | 19.0% | 11.0% | 16.0% | 16.0% | — |
| Exceptional items | −3.99 | −0.99 | 0.00 | 0.00 | −10.98 | −5.98 | −6.98 | 7.98 | 0.99 | 2.99 | −32.88 | −45.84 |
| Net Profit | 21.04 | 83.16 | 51.13 | 59.17 | 119 | −14.03 | 343 | 608 | 792 | 793 | 807 | 818 |
| EPS (Rs) | 1.03 | 4.05 | 2.50 | 2.89 | 5.83 | −0.69 | 16.72 | 29.63 | 38.61 | 38.65 | 39.38 | 39.90 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 35.0% | 17.0% | 0.0% | 6.0% | 8.0% | 10.0% | 12.0% | 11.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 199 | 203 | 203 | 203 | 203 | 203 | 204 | 203 | 203 | 203 | 203 | 203 |
| Reserves | 568 | 672 | 759 | 831 | 877 | 932 | 917 | 1,284 | 1,925 | 2,680 | 3,423 | 4,333 |
| Borrowings | 361 | 257 | 216 | 800 | 810 | 950 | 824 | 721 | 881 | 1,623 | 2,421 | 5,840 |
| Other Liabilities | 240 | 422 | 466 | 689 | 742 | 809 | 829 | 927 | 1,149 | 1,118 | 1,210 | 2,078 |
| Total Liabilities | 1,368 | 1,554 | 1,644 | 2,523 | 2,633 | 2,894 | 2,773 | 3,136 | 4,159 | 5,623 | 7,259 | 12,454 |
| Fixed Assets | 911 | 1,052 | 1,079 | 1,844 | 1,833 | 2,086 | 1,957 | 1,975 | 2,329 | 2,646 | 4,257 | 7,774 |
| CWIP | 19.94 | 13.96 | 52.81 | 34.89 | 55.83 | 11.96 | 19.94 | 66.84 | 258 | 513 | 85.72 | 291 |
| Investments | 52.07 | 87.23 | 96.20 | 9.03 | 17.03 | 86.16 | 120 | 132 | 253 | 845 | 1,087 | 575 |
| Other Assets | 384 | 401 | 416 | 635 | 727 | 709 | 676 | 962 | 1,319 | 1,620 | 1,830 | 3,814 |
| Inventories | 52.13 | 51.12 | 53.16 | 85.19 | 91.16 | 72.17 | 59.11 | 74.22 | 85.28 | 124 | 124 | 174 |
| Trade receivables | 143 | 152 | 157 | 280 | 267 | 263 | 279 | 438 | 433 | 423 | 556 | 658 |
| Cash & equivalents | 29.96 | 23.97 | 33.96 | 34.96 | 101 | 115 | 132 | 172 | 380 | 416 | 647 | 2,128 |
| Total Assets | 1,368 | 1,554 | 1,644 | 2,523 | 2,633 | 2,894 | 2,773 | 3,136 | 4,159 | 5,623 | 7,259 | 12,454 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 76.99 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,068 | 986 | 1,621 |
| Cash from investing activity | −224 | −151 | −146 | −521 | −163 | −190 | −113 | −268 | −1,181 | −1,464 | −1,329 | −3,658 |
| Cash from financing activity | 140 | 18.01 | −45.02 | 315 | −27.01 | −247 | −194 | −159 | 88.07 | 488 | 544 | 2,341 |
| Net cash flow | −6.01 | 42.01 | 28.01 | −22.03 | 89.11 | 6.99 | −2.01 | 59.09 | −4.01 | 97.08 | 205 | 313 |
| Capex | 98.01 | 90.04 | 135 | 204 | 150 | 116 | 70.01 | 251 | 522 | 972 | 1,083 | 876 |
| Free cash flow | −15.03 | 86.16 | 85.16 | −20.06 | 129 | 330 | 236 | 235 | 564 | 99.26 | −93.20 | 755 |
| CFO / OP % | 77.9% | 116.0% | 108.0% | 100.0% | 113.0% | 116.9% | 133.0% | 83.0% | 118.9% | 98.9% | 85.9% | 108.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 39 | 35 | 31 | 46 | 35 | 32 | 40 | 44 | 36 | 32 | 38 | 31 |
| Inventory days | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 44 | 40 | 42 |
| Days payable | 147 | 153 | 174 | 201 | 178 | 178 | 222 | 181 | 225 | 215 | 186 | 249 |
| Cash conversion cycle | −51 | −70 | −98 | −100 | −95 | −111 | −150 | −108 | −158 | −138 | −108 | −176 |
| Working capital days | −31 | −13 | −12 | −11 | −11 | −23 | −39 | −17 | −26 | −31 | −18 | −20 |
| ROCE % | 6.9% | 8.9% | 13.9% | 8.9% | 8.9% | 13.9% | 2.0% | 24.9% | 31.9% | 25.9% | 21.0% | 15.9% |
For the Jun 2026 quarter, Narayana Hrudayalaya reported sales of ₹2,678 Cr, up 78.1% year on year and net profit of ₹208 Cr, up 5.0% year on year. The operating margin was 17.1%.
Narayana Hrudayalaya's sales for the year to Mar 2026 were ₹7,886 Cr; over the last twelve months they were ₹9,056 Cr.
Net profit for the year to Mar 2026 was ₹807 Cr, and ₹818 Cr over the last twelve months. Earnings per share over the same trailing period were ₹39.90.
Narayana Hrudayalaya reported borrowings of ₹5,840 Cr at Mar 2026, against cash and equivalents of ₹2,128 Cr.
Cash from operations was ₹1,621 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹755 Cr.